Cargando…

Antibody responses against heterologous H5N1 strains for an MF59-adjuvanted cell culture–derived H5N1 (aH5n1c) influenza vaccine in adults and older adults

MF59-adjuvanted H5N1, cell culture-derived inactivated influenza vaccine (aH5N1c, AUDENZ®, Seqirus) is available for persons 6 months of age and older. During a pandemic, lack of preexisting immunity to novel influenza strains increases morbidity and mortality. This study examined the potential for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frey, Sharon S., Versage, Eve, Van Twuijver, Esther, Hohenboken, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Influenza
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114991/ https://www.ncbi.nlm.nih.gov/pubmed/37057755 http://dx.doi.org/10.1080/21645515.2023.2193119

Ejemplares similares

Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults
por: Versage, Eve, et al.
Publicado: (2021)

Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
por: Le, Ly, et al.
Publicado: (2011)

Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects
por: Peterson, James, et al.
Publicado: (2022)

Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020
por: Lewis, Nicola S., et al.
Publicado: (2021)

The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009)

The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study
por: Wei, Sung-Hsi, et al.
Publicado: (2014)

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza
por: Ross, Ted, et al.
Publicado: (2010)

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom
por: Ghani, Azra, et al.
Publicado: (2010)

The severity of pandemic H1N1 influenza in the United States, April – July 2009
por: Presanis, Anne M, et al.
Publicado: (2010)

Fatal cases associated with pandemic influenza A (H1N1) reported in Greece.
por: Athanasiou, Maria, et al.
Publicado: (2010)

Symptomatic infections less frequent with H1N1pdm than with seasonal strains
por: Flahault, Antoine, et al.
Publicado: (2009)

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination
por: Goll, Johannes B., et al.
Publicado: (2022)

Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan
por: Kamigaki, Taro, et al.
Publicado: (2009)

Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly
por: Frey, Sharon E, et al.
Publicado: (2019)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking
por: Nguyen, Hung, et al.
Publicado: (2011)

Swine to human transmission of reassortants of pandemic (H1N1) 2009 and endemic swine influenza viruses: Abstract
por: de Silva, U. Chandimal, et al.
Publicado: (2011)

Highly pathogenic avian influenza (A/H5N1) virus outbreaks in Lesotho, May 2021
por: Makalo, Mabusetsa R.J., et al.
Publicado: (2022)

Characterization of the haemagglutinin properties of the H5N1 avian influenza virus that caused human infections in Cambodia
por: Chang, Pengxiang, et al.
Publicado: (2023)

Identification of Influenza Cases During the H1N1 Pandemic in Massachusetts Using Population-Based Hospital Discharge Data
por: Placzek, Hilary, et al.
Publicado: (2011)

Recrudescent wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: Age shift and severity
por: Chowell, Gerardo, et al.
Publicado: (2012)

Critical paths in a metapopulation model of H1N1: Efficiently delaying influenza spreading through flight cancellation
por: Marcelino, Jose, et al.
Publicado: (2012)

Next Generation Syndromic Surveillance: Molecular Epidemiology, Electronic Health Records and the Pandemic Influenza A (H1N1) Virus
por: Rabadan, Raul, et al.
Publicado: (2009)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Highly pathogenic avian influenza H5N1 virus outbreak among Cape cormorants (Phalacrocorax capensis) in Namibia, 2022
por: Molini, Umberto, et al.
Publicado: (2023)

Novel H5N6 reassortants bearing the clade 2.3.4.4b HA gene of H5N8 virus have been detected in poultry and caused multiple human infections in China
por: Gu, Wenli, et al.
Publicado: (2022)

Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence
por: Ma, Ning, et al.
Publicado: (2023)

Emergence, prevalence, and evolution of H5N8 avian influenza viruses in central China, 2020
por: Li, Xiang, et al.
Publicado: (2021)

Characterization of neurotropic HPAI H5N1 viruses with novel genome constellations and mammalian adaptive mutations in free-living mesocarnivores in Canada
por: Alkie, Tamiru N., et al.
Publicado: (2023)

Código A (H1N1) : diario de una pandemia /
por: Ortiz Quesada, Federico
Publicado: (2009)

Weekly influenza-like-Illness rates were significantly lower in areas where schools were not in session in the United States during the 2009 H1N1 pandemic.
por: Briffault, Olivia
Publicado: (2011)

MF59(®)-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
por: Banzhoff, Angelika, et al.
Publicado: (2009)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2014)

Human infection with avian-origin H5N6 influenza a virus after exposure to slaughtered poultry
por: Li, Jun, et al.
Publicado: (2022)

A variant NS1 protein from H5N2 avian influenza virus suppresses PKR activation and promotes replication and virulence in mammals
por: Chung, Yun-Ting, et al.
Publicado: (2022)

Correction: MF59(®)-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
por: Banzhoff, Angelika, et al.
Publicado: (2009)

Clinical features of the first critical case of acute encephalitis caused by the avian influenza A (H5N6) virus
por: Zhang, Libing, et al.
Publicado: (2022)

Overview of the winter wave of 2009 pandemic influenza A(H1N1)v in Vojvodina, Serbia
por: Petrović, Vladimir, et al.
Publicado: (2011)

Pandemic influenza A (H1N1) virus causes abortive infection of primary human T cells
por: Yu, Jiapei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v1sro5fuv60ulik39vgaikednj